Gajus Worthington

Gajus Worthington is a life sciences entrepreneur, engineer, and inventor who turned an idea for circuits that move fluid instead of electrons into Fluidigm, a microfluidics company he co-founded in 1999 and led as CEO through its IPO and years as a public company. Today he is Chairman and CEO of Superfluid Dx, a South San Francisco company building a blood test that reads cell-free messenger RNA from the brain to diagnose Alzheimer's disease earlier and more precisely. Between those chapters he served as COO of the Chan Zuckerberg Biohub, co-founded Kaizen Therapeutics and the ML/AI healthcare company StatOS, and became a Managing Partner at WRQ Sciences.